Dimerix Ltd - Asset Resilience Ratio

Latest as of June 2025: 74.89%

Dimerix Ltd (DXB) has an Asset Resilience Ratio of 74.89% as of June 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.

Liquid Assets

AU$68.28 Million

≈ $48.32 Million USD Cash + Short-term Investments

Total Assets

AU$91.18 Million

≈ $64.51 Million USD All company assets

Resilience Assessment

Very High

Financial Resilience Level

Asset Resilience Ratio Trend (2002–2025)

This chart shows how Dimerix Ltd's Asset Resilience Ratio has changed over time. Check DXB capital-intensive asset ratio to assess the company's strategic physical and investment asset allocation.

Liquid Assets Composition Over Time

This chart breaks down Dimerix Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see Dimerix Ltd market cap and net worth.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	AU$68.28 Million	74.89%
Short-term Investments	AU$0.00	0%
Total Liquid Assets	AU$68.28 Million	74.89%

Asset Resilience Insights

Very High Liquidity: Dimerix Ltd maintains exceptional liquid asset reserves at 74.89% of total assets.
This level provides strong protection against economic uncertainties but may indicate potential for more aggressive growth investments.
The company primarily holds liquidity in cash and equivalents rather than short-term investments.

Dimerix Ltd Industry Peers by Asset Resilience Ratio

Compare Dimerix Ltd's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Ascendis Pharma AS NASDAQ:ASND	Biotechnology	0.00%
Halozyme Therapeutics Inc NASDAQ:HALO	Biotechnology	12.71%
Akero Therapeutics Inc NASDAQ:AKRO	Biotechnology	55.87%
Beijing Tiantan Biological Products Corp Ltd SHG:600161	Biotechnology	8.08%
Zealand Pharma A/S CO:ZEAL	Biotechnology	63.98%
Verona Pharma PLC ADR NASDAQ:VRNA	Biotechnology	0.00%
Immunitybio Inc NASDAQ:IBRX	Biotechnology	38.07%
Tibet Cheezheng Tibetan Medicine Co Ltd SHE:002287	Biotechnology	37.31%

Annual Asset Resilience Ratio for Dimerix Ltd (2002–2025)

The table below shows the annual Asset Resilience Ratio data for Dimerix Ltd.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2025-06-30	74.89%	AU$68.28 Million ≈ $48.32 Million	AU$91.18 Million ≈ $64.51 Million	+5.87pp
2024-06-30	69.02%	AU$22.14 Million ≈ $15.67 Million	AU$32.08 Million ≈ $22.70 Million	+24.02pp
2023-06-30	45.01%	AU$7.99 Million ≈ $5.65 Million	AU$17.76 Million ≈ $12.56 Million	-13.37pp
2022-06-30	58.37%	AU$9.63 Million ≈ $6.81 Million	AU$16.50 Million ≈ $11.67 Million	+2.64pp
2021-06-30	55.73%	AU$5.25 Million ≈ $3.71 Million	AU$9.42 Million ≈ $6.67 Million	-19.21pp
2020-06-30	74.94%	AU$7.79 Million ≈ $5.51 Million	AU$10.39 Million ≈ $7.35 Million	+2.82pp
2019-06-30	72.12%	AU$3.56 Million ≈ $2.52 Million	AU$4.94 Million ≈ $3.50 Million	-14.38pp
2018-06-30	86.50%	AU$6.28 Million ≈ $4.45 Million	AU$7.26 Million ≈ $5.14 Million	+8.35pp
2017-06-30	78.16%	AU$2.24 Million ≈ $1.59 Million	AU$2.87 Million ≈ $2.03 Million	+44.28pp
2013-06-30	33.88%	AU$594.05K ≈ $420.33K	AU$1.75 Million ≈ $1.24 Million	-50.95pp
2012-06-30	84.83%	AU$1.03 Million ≈ $728.83K	AU$1.21 Million ≈ $859.19K	+58.22pp
2011-06-30	26.60%	AU$424.00K ≈ $300.01K	AU$1.59 Million ≈ $1.13 Million	+10.73pp
2002-06-30	15.87%	AU$300.00K ≈ $212.27K	AU$1.89 Million ≈ $1.34 Million	--

pp = percentage points

About Dimerix Ltd

AU:DXB Australia Biotechnology

Market Cap

$104.08 Million

AU$147.10 Million AUD

Market Cap Rank

#18986 Global

#609 in Australia

Share Price

AU$0.25

Change (1 day)

-2.00%

52-Week Range

AU$0.17 - AU$0.63

All Time High

AU$0.77